Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A randomized, double-blind, placebo-controlled clinical trial of Bupropion for the prevention of smoking in youth with attention-deifcit/hyperactivity disorder

A randomized, double-blind, placebo-controlled clinical trial of Bupropion for the prevention of smoking in youth with attention-deifcit/hyperactivity disorder. Proceedings of the NCI Tobacco Control Investigator's Meeting: Synthesizing Research for the Public's Health. 2004.


© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.